Glycyx Mor, Inc.
San Francisco, CA Glycyx Mor, Inc.
- UEI
- C2B7XPCFTHC7
- CAGE
- 91G26
- Primary NAICS
- 325412 Pharmaceutical Preparation Manufacturing
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Physical address
- 330 24th Ave #3, San Francisco, CA 94121, USA
- Website
- glycyx.com
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| A phase 2 trial of axelopran plus pembrolizumab for the first-line treatment of recurrent/metastatic hnscc that is PD-L1… | National Cancer Institute | $1,197,275 |
Quick answers
What is Glycyx Mor, Inc.'s UEI?
Glycyx Mor, Inc.'s Unique Entity ID (UEI) in SAM.gov is C2B7XPCFTHC7.
What is Glycyx Mor, Inc.'s CAGE code?
Glycyx Mor, Inc.'s CAGE code is 91G26.
What is Glycyx Mor, Inc.'s primary NAICS code?
Glycyx Mor, Inc.'s primary NAICS code is 325412 (Pharmaceutical Preparation Manufacturing).
Where is Glycyx Mor, Inc. located?
Glycyx Mor, Inc.'s physical address in SAM.gov is 330 24th Ave #3, San Francisco, CA 94121, USA.
Is Glycyx Mor, Inc. registered in SAM.gov?
Yes. Glycyx Mor, Inc.'s SAM.gov registration is active through June 16, 2027.
What is Glycyx Mor, Inc.'s most recent federal award?
Glycyx Mor, Inc.'s most recent federal grant award is A phase 2 trial of axelopran plus pembrolizumab for the first-line treatment of recurrent/metastatic hnscc that is PD-L1… (R44CA306565), from National Cancer Institute, on September 19, 2025.
On GovTribe
See Glycyx Mor, Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors